CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleMarket cap is $1.5B, above the global median of $1.15B
- FinancialsAltman Z-Score 1.92: grey zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.03%Above 5Y avg (1.07%)
Annual Rate
CNY 0.27Paid annual
Payout Ratio
42.3%Sustainable
Payback Period
48.9 yr
Last Ex-Dividend
Jul 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.07BCNY1.50B · vs all stocks (USD)
Trailing P/E
25.04xvs Pharmaceutical Retailers peers
Revenue (TTM)
22.28BCNY3.31B · vs all stocks (USD)
Profit Margin
1.77%vs Pharmaceutical Retailers peers
Beta
0.4340xvs all stocks
52-Week Change
-27.99%vs all stocks
Market Capitalization
10.07BCNY1.50B · vs all stocks (USD)
Enterprise Value
12.29BCNY1.83B · vs all stocks (USD)
Trailing P/E
25.04xvs Pharmaceutical Retailers peers
Forward P/E
9.90xvs Pharmaceutical Retailers peers
Price to Sales (TTM)
0.4519xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
1.48xvs Pharmaceutical Retailers peers
Enterprise to Revenue
0.5520xvs Pharmaceutical Retailers peers
Enterprise to EBITDA
8.50xvs Pharmaceutical Retailers peers
Gross Margin
33.51%vs Pharmaceutical Retailers peers
Profit Margin
1.77%vs Pharmaceutical Retailers peers
Operating Margin
7.55%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
3.37%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
7.54%vs Pharmaceutical Retailers peers
Revenue (TTM)
22.28BCNY3.31B · vs all stocks (USD)
Revenue per Share (TTM)
29.23CNYUpdated Aug 21, 2026Quarterly Revenue Growth
0.80%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
7.15BCNY1.06B · vs all stocks (USD)
EBITDA (TTM)
1.37BCNY204.00M · vs all stocks (USD)
Net Income (TTM)
395.07MCNY58.75M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
5.30%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
3.20BCNY475.42M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
2.26BCNY336.27M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2700CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
2.03%vs all stocks
5-Year Average Dividend Yield
1.07%vs all stocks
Payout Ratio
42.31%vs Pharmaceutical Retailers peers
Minority Interest (Equity)
460.70MCNYFY2025 · Dec 31, 2025Revenue
22.24BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
15.05BCNYFY2025 · Dec 31, 2025Gross Profit
7.18BCNYFY2025 · Dec 31, 2025Operating Income
1.14BCNY170.24M · vs all stocks (USD)
Pre-tax Income
756.17MCNYFY2025 · Dec 31, 2025Income Tax Expense
215.72MCNYFY2025 · Dec 31, 2025Net Income
540.45MCNYFY2025 · Dec 31, 2025EBIT
886.44MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.60BCNYFY2025 · Dec 31, 2025Research & Development
51.07MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
2.08BCNYFY2025 · Dec 31, 2025Other Operating Expenses
152.69MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
13.37MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
130.27MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.5000CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.5000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
763.69MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
763.69MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
540.45MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-158.60MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
1.21BCNYFY2025 · Dec 31, 2025Free Cash Flow
968.26MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.14BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
540.45MCNYFY2025 · Dec 31, 2025Other Non-cash Items
310.22MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
469.25MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-106.48MCNYFY2025 · Dec 31, 2025Capital Expenditures
-245.19MCNYFY2025 · Dec 31, 2025Net Acquisitions
-3.20MCNYFY2025 · Dec 31, 2025Purchase of Investments
-644.46KCNYFY2025 · Dec 31, 2025Sale of Investments
12.37MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-236.66MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.90BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-2.70BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-224.62MCNYFY2025 · Dec 31, 2025Other Financing Charges
-1.58BCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-2.60BCNYFY2025 · Dec 31, 2025Shares Outstanding
758.89MSharesUpdated Aug 21, 2026Float Shares
379.21MSharesUpdated Aug 21, 2026% Held by Insiders
50.24%vs all stocks
% Held by Institutions
2.58%vs all stocks
Total Cash (MRQ)
2.67BCNY396.84M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.52CNYUpdated Aug 21, 2026Total Debt (MRQ)
4.39BCNY652.91M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.6016xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
0.8970xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
8.96CNYUpdated Aug 21, 2026Total Assets
19.85BCNY2.95B · vs all stocks (USD)
Total Current Assets
8.83BCNYFY2025 · Dec 31, 2025Total Liabilities
12.85BCNYFY2025 · Dec 31, 2025Total Non-current Assets
11.01BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.69BCNYFY2025 · Dec 31, 2025Total Current Liabilities
10.16BCNYFY2025 · Dec 31, 2025Cash
1.12BCNYFY2025 · Dec 31, 2025Cash Equivalents
1.23BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.36BCNYFY2025 · Dec 31, 2025Accounts Receivable
2.11BCNYFY2025 · Dec 31, 2025Inventory
3.65BCNYFY2025 · Dec 31, 2025Accounts Payable
6.76BCNYFY2025 · Dec 31, 2025Short-term Debt
1.92BCNYFY2025 · Dec 31, 2025Other Current Liabilities
32.05MCNYFY2025 · Dec 31, 2025Long-term Debt
2.64BCNYFY2025 · Dec 31, 2025Common Stock (Book)
758.89MCNYFY2025 · Dec 31, 2025Retained Earnings
3.72BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
7.00BCNY1.04B · vs all stocks (USD)
52-Week Low
10.67CNYUpdated Aug 21, 202652-Week High
18.73CNYUpdated Aug 21, 202652-Week Change
-27.99%vs all stocks
Beta
0.4340xvs all stocks
50-Day MA
12.18CNYUpdated Aug 21, 2026200-Day MA
13.97CNYUpdated Aug 21, 2026Avg 10-Day Volume
24.20MSharesUpdated Aug 21, 2026Avg 30-Day Volume
16.41MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.5300CNYUpdated Aug 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
Where is this company structurally exposed?
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.92: grey zoneSignificant
Altman Z-Score: 1.92
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Market cap is $1.5B, above the global median of $1.15BNotable
Market cap (USD): 1,497,580,103.924Global Median: 1,146,734,693.424
Revenue is $3.31B, above the global median of $520.53MNotable
Revenue (USD): 3,313,659,217.736Global Median: 520,528,949.311
Levered free cash flow is $336.27M, above the global median of $16.24MNotable
Levered free cash flow (USD): 336,267,106.429Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Com7 Public Company Limited
Tier 1FlowUnit ReplicationInterfaceAttention
Savers Value Village Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Redcare Pharmacy N.V.
Tier 1FlowUnit ReplicationInterfaceProduction
Winmark Corporation
Tier 1FlowUnit ReplicationProductionInterface
Sally Beauty Holdings Inc.
Tier 1FlowUnit ReplicationInterfaceSenseMaking
Carter's Inc.
Tier 1FlowUnit ReplicationRiskInterface
Kidswant Children Products Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRisk
E-Mart Inc.
Tier 1FlowUnit ReplicationInterfaceProduction
Max Stock Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Create SD Holdings Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Myoung Shin Industrial Co., Ltd.
3 interpretationsClose Below 40W SMA With ProfitabilityDrawdown With FCF And Cash BackingPartial Recovery After Sharp Decline
Shandong Publishing & Media Co., Ltd.
3 interpretationsClose Below 40W SMA With ProfitabilityDrawdown With FCF And Cash BackingPartial Recovery After Sharp Decline
Johnson Fine Chemical Co., Ltd.
3 interpretationsClose Below 40W SMA With ProfitabilityDrawdown With FCF And Cash BackingPartial Recovery After Sharp Decline